To assess the effectiveness of TCLN technology in detecting RNA biomarkers in PCa-derived EVs, EVs were isolated from the PC3 metastatic prostate cancer cell line and analysed for the co-localisation of miR−141 with CD63-labelled EVs. Here, CD63 is linked to prostate cancer.